Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study
2022 · Journal of Gastrointestinal Cancer · 9 citations
https://doi.org/10.1007/s12029-022-00815-1
S
Shoko Marshall
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
87
Citations
6
h-index
3
i10-index
Shoko Marshall is an academic researcher from Tokyo Women's Medical University Adachi Medical Center. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Myeloproliferative Neoplasms: Diagnosis and Treatment & Acute Myeloid Leukemia Research. The author has an h-index of 6, co-authored 26 publications.
ORCID: 0000-0002-6035-3487Papers by this author
worksJAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review
2020 · Leukemia Research Reports · 0 citations
https://doi.org/10.1016/j.lrr.2019.100194
530P Comparison of hyperbaric oxygen therapy and long intestinal tube therapy for postoperative adhesive small bowel obstruction in gastrointestinal cancer patients
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.557
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat